Johnson & Johnson’s Kenvue consumer health business is preparing for an initial public offering of more than 151 million...

Johnson & Johnson beat first-quarter expectations, as growth in the health care giant’s home market helped counter anoth...

Johnson & Johnson is earmarking nearly $9 billion to cover allegations that its baby power containing talc caused cancer

Johnson & Johnson topped third-quarter expectations thanks to growth in pharmaceutical sales, but the health care giant...

Johnson & Johnson rode growing sales of the cancer treatment Darzalex and other key drugs to a better-than-expected seco...

The Food and Drug Administration has limited its authorization of the Johnson & Johnson COVID-19 vaccine due to the rare...

U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious ris...

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could b...

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the o...

Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, a...